ClinConnect ClinConnect Logo
Search / Trial NCT00638235

Pelvic Floor Repair Systems for Prolapse Repair

Launched by ASTORA WOMEN'S HEALTH · Mar 18, 2008

Trial Information

Current as of July 21, 2025

Completed

Keywords

Pelvic Floor Repair Prolapse Mesh

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • -Have been diagnosed with one or more clinically significant anterior, apical or posterior genital prolapse disorder(s) (symptomatic POP-Q stage II or higher) requiring surgical repair
  • Exclusion Criteria:
  • The Investigator determines the subject is not a candidate for surgical repair of her genital prolapse.
  • Subject has had a prior prolapse implant/procedure (i.e., IVS tunneler, Perigee, Apogee, graft augmented repair, etc) Note: previous traditional repairs are allowed.
  • Subject has active or latent systemic infection or signs of tissue necrosis.
  • Subject has restricted leg motion (inability to abduct or adduct leg positioning in the lithotomy position) with or without a hip replacement/prosthesis.
  • Subject is currently pregnant or intends to become pregnant during the study period. Note: the risks and benefits of performing the procedure if the subject is planning future pregnancies should be carefully considered.
  • Subject has had radiation therapy to the pelvic area.
  • Subject has pelvic cancer, has had pelvic cancer within the past 12 months or has been on cytostatic medication within the past 12 months.
  • Subject has a known hypersensitivity to the graft material(s).
  • Subject has uncontrolled diabetes.
  • Subject is on any medication which could result in compromised immune response, such as immune modulators.
  • Subject was involved in any other research trial \< 30 days of enrollment into this study.
  • Subject has undergone previous pelvic surgery \< 6 months prior to enrollment in this study.
  • Subject is unwilling or unable to give valid informed consent.
  • Subject is unwilling or unable to comply with the requirements of the protocol, complete all Quality of Life questionnaires and return for all follow-up visits.
  • Subject is contraindicated based on intended use and warnings in the AMS PFR System devices for prolapse repair Instructions for Use (IFU).

About Astora Women's Health

Astora Women's Health is a pioneering medical device company dedicated to improving women's health outcomes through innovative solutions. Focused on developing and commercializing advanced technologies for gynecological conditions, Astora aims to empower healthcare providers with effective tools that enhance patient care. With a commitment to rigorous clinical research and collaboration with medical professionals, Astora strives to address unmet needs in women's health, ensuring safety, efficacy, and improved quality of life for patients worldwide.

Locations

Norfolk, Virginia, United States

Wellington, Florida, United States

Plymouth, Minnesota, United States

Alpharetta, Georgia, United States

Idaho Falls, Idaho, United States

Paw Paw, Michigan, United States

Downey, California, United States

Portland, Maine, United States

Portland, Maine, United States

Whitinsville, Massachusetts, United States

Grand Rapids, Michigan, United States

Grand Rapids, Michigan, United States

Gastonia, North Carolina, United States

Englewood, Ohio, United States

Columbia, South Carolina, United States

Memphis, Tennessee, United States

El Paso, Texas, United States

Leuven, , Belgium

Montpellier, , France

Paris, , France

Paris, , France

Rouen, , France

Strasbourg, , France

Alzey, , Germany

Munich, , Germany

Amsterdam, , Netherlands

Barcelona, , Spain

Leicester, , United Kingdom

Patients applied

0 patients applied

Trial Officials

James C. Lukban, DO

Principal Investigator

Eastern Virginia Medical School

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials